Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)-Reference-Cited by-同舟云学术

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

Published:2015-04 Issue:4 Volume:15 Page:397-404
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Bourlière Marc,Bronowicki Jean-Pierre,de Ledinghen Victor,Hézode Christophe,Zoulim Fabien,Mathurin Philippe,Tran Albert,Larrey Dominique G,Ratziu Vlad,Alric Laurent,Hyland Robert H,Jiang Deyuan,Doehle Brian,Pang Phillip S,Symonds William T,Subramanian G Mani,McHutchison John G,Marcellin Patrick,Habersetzer François,Guyader Dominique,Grangé Jean-Didier,Loustaud-Ratti Véronique,Serfaty Lawrence,Metivier Sophie,Leroy Vincent,Abergel Armand,Pol Stanislas

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference19 articles.

1. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection;Jacobson;Clin Gastroenterol Hepatol,2010

2. Perspectives on fibrosis progression in hepatitis C: an à la carte approach to risk factors and staging of fibrosis;Poynard;Antivir Ther,2010

3. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis;Veldt;Ann Intern Med,2007

4. Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis: a 12-year prospective follow-up study;Bruno;Hepatology,2010

5. A sustained virologic response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus;Singal;Clin Gastroenterol Hepatol,2010

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Survival and Cancer Risk in the Hepatitis C Virus-Infected Patients After Antiviral Treatment: A Nationwide Cohort Study;Journal of Cancer;2024

2. Efficacy of combined antiretroviral therapy (cART) in Hepatitis B and C associated hepatocellular carcinoma (HCC): a narrative review;Journal of Human Virology & Retrovirology;2023-12-29

3. Clinical Pharmacology Applications of Real‐World Data and Real‐World Evidence in Drug Development and Approval–An Industry Perspective;Clinical Pharmacology & Therapeutics;2023-07-29

4. Effectiveness of Glecaprevir/Pibrentasvir in Patients with Chronic HCV-infection Genotypes 1 to 6 in the real-world settings in Russia (EVEREST study);Journal Infectology;2023-07-06

5. Current Landscape of HCV Therapeutics;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01